Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B8GA
|
|||
Drug Name |
Isoxazole-based bicyclic compound 5
|
|||
Synonyms |
PMID26924192-Compound-65
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ZENITH EPIGENETICS CORP
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H21N5O3
|
|||
Canonical SMILES |
CCNC1=NC2=C(N1CC3=CC=CC=C3)C=C(C=C2[N+](=O)[O-])C4=C(ON=C4C)C
|
|||
InChI |
1S/C21H21N5O3/c1-4-22-21-23-20-17(25(21)12-15-8-6-5-7-9-15)10-16(11-18(20)26(27)28)19-13(2)24-29-14(19)3/h5-11H,4,12H2,1-3H3,(H,22,23)
|
|||
InChIKey |
ANFSRXMOJNUJCH-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
Target's Patent Info | Bromodomain and extraterminal domain protein (BET) | Target's Patent Info | [1] | |
KEGG Pathway | SNARE interactions in vesicular transport | |||
Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase |
References | Top | |||
---|---|---|---|---|
REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.